Taking popular GLP-1 class weight loss drugs like Ozempic and Wegovy could be linked to a higher risk of developing osteoporosis, gout and a condition that causes severe bone softening compared to people who don’t use the medications, researchers said Monday.

https://www.independent.co.uk/news/health/weight-loss-drugs-new-risks-b2930272.html

#Independent